European Association for Hemophilia and Allied Disorders (EAHAD 2026)
3 - 6 February 2026
Real-world efficacy and safety of concizumab in patients with haemophilia B with inhibitors from the early access program in France
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.